BMN-673 (8R,9S)

Modify Date: 2024-01-02 10:30:22

BMN-673 (8R,9S) Structure
BMN-673 (8R,9S) structure
Common Name BMN-673 (8R,9S)
CAS Number 1207456-00-5 Molecular Weight 380.35100
Density N/A Boiling Point N/A
Molecular Formula C19H14F2N6O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of BMN-673 (8R,9S)


Talazoparib 8R,9S (BMN-673 8R,9S) is an enantiomer of Talazoparib, less active than Talazoparib on the inhibition of PARP1, with an IC50 of 144 nM.

 Names

Name (8R,9S)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3 ,2-de] phthalazin-3(7H)-one
Synonym More Synonyms

 BMN-673 (8R,9S) Biological Activity

Description Talazoparib 8R,9S (BMN-673 8R,9S) is an enantiomer of Talazoparib, less active than Talazoparib on the inhibition of PARP1, with an IC50 of 144 nM.
Related Catalog
Target

PARP-1:144 nM (IC50)

References

[1]. Wang B, et al. Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-

 Chemical & Physical Properties

Molecular Formula C19H14F2N6O
Molecular Weight 380.35100
Exact Mass 380.12000
PSA 91.98000
LogP 1.89830

 Synthetic Route

 Synonyms

(8R,9S)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one
BMN-673 8R,9S||BMN673 (8R,9S)|BMN 673 (8R,9S)
BMN 673 (8R,9S)
CS-1223
BMN-673 (8R,9S)
Top Suppliers:I want be here




Get all suppliers and price by the below link:

BMN-673 (8R,9S) suppliers


Price: $198/10mM*1mLinDMSO

Reference only. check more BMN-673 (8R,9S) price

Related Compounds: More...
BMN 673
1207454-56-5
(4R,5R,8R,9S,12R,13R)-9-hydroxy-12,13-isopropylidenedioxy-5,8-oxidotricosa-1,4-olide
181803-40-7
(3S,5R,8R,9S,10S,13S,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol
5856-11-1
[(3S,5S,8R,9S,10S,13S,14S,16E)-16-(acetyloxymethylidene)-10,13-dimethyl-17-oxo-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
5767-88-4
(3R,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol
25126-76-5
[(3S,5S,8R,9S,10S,13R,14S,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
6562-14-7
14-hydroxyestrone
5949-46-2
(4R,5R,8R,9S)-9-hydroxy-5,8-oxidotricosa-12-en-1,4-olide
303052-90-6
(3R,5S,8R,9S,10S,13S,14S,16S)-3,16-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one
66791-83-1
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
tert-Butyl-DL-alanine
1375289-11-4
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
849349-65-1
N-[3-(Aminooxy)propyl]-N-butyl-1-butanamine
127437-46-1